K Verboven, D Hansen, C Moro, BO Eijnde… - Clinical …, 2016 - portlandpress.com
Catecholamines and atrial natriuretic peptide (ANP) are major regulators of adipocyte lipolysis. Although obesity is characterized by catecholamine resistance in subcutaneous …
A Sharma, KI Birkeland, I Nermoen, C Sommer… - Cardiovascular …, 2024 - Springer
Abstract Background Individuals of South Asian origin have a greater risk of cardiovascular disease after gestational diabetes mellitus (GDM) than European individuals. B-type …
Y Mizuno, E Harada, D Katoh, Y Kashiwagi… - Endocrine …, 2013 - jstage.jst.go.jp
B-type natriuretic peptide (BNP) is produced by the heart and its plasma level is increased with the severity of left ventricular (LV) dysfunction/hypertrophy. The normal heart …
Introduction Persons with diabetes are at risk for developing a cardiomyopathy through several pathophysiological mechanisms independent of traditional risk factors for heart …
L Larifla, C Rambhojan, MO Joannes… - PLoS …, 2016 - journals.plos.org
Objectives The metabolic syndrome (MetS) is a cluster of metabolic abnormalities and cardiovascular risk factors that are highly heritable and polygenic. We investigated the …
We examined the hypothesis that insulin resistance (IR) decreases circulating concentrations of N-terminal (NT)-probrain natriuretic peptide (BNP). Obesity, despite being …
N Abrahamsson, BE Engström, M Sundbom… - Obesity Surgery, 2013 - Springer
Background Brain natriuretic peptide (BNP) is produced in the heart in response to stretching of the myocardium. BNP levels are negatively correlated to obesity, and in obese …
M Onodera, M Nakamura, F Tanaka… - International Heart …, 2012 - jstage.jst.go.jp
Diabetes mellitus (DM) is a strong risk factor for cardiovascular (CV) disease. Plasma B-type natriuretic peptide (BNP) levels are elevated in various types of cardiac diseases. Increased …